Enhancers that direct gene expression to central nervous system vascular endothelial cells in vivo

Read full text Summarise with VIRAT
Authors: Zhongming Li, Amir Rattner, Yanshu Wang, Philip M. Smallwood, Mark F Sabbagh, Brandon J. Mannion, Len A. Pennacchio, Jeremy Nathans
Cited by: 0
References: 81

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

CNS vascular endothelial cells (ECs) exhibit a distinctive gene expression program that is foundational for the blood-brain barrier (BBB). Previous research identified candidate cis-regulatory elements (CREs) that were hypothesized to control this program. In this work, transgenic mice and recombinant adeno-associated virus (rAAV) vectors have been used to interrogate these candidate CREs in vivo. These experiments show that an 850 bp genomic DNA segment ∼60 kb 5' of Slc2a1 possesses enhancer activity that is (1) specific for BBB+ CNS ECs and (2) both necessary and sufficient for BBB+ EC gene expression. A screen of >8,000 genomic DNA segments from CNS EC-specific CRE candidates reveals several hundred with enhancer activity. Transcription factors ERG and LEF1 are shown to occupy sites in brain ECs that are highly enriched in candidate and experimentally validated CREs, lending strong support to a model in which canonical Wnt signaling activates the BBB program via LEF1.

Fields of Study & Subjects

Barrier Structure and Function Studies Genomics and Chromatin Dynamics Drug Transport and Resistance Mechanisms

Publication details

Journal / source
Neuron
Volume
114
Issue
10
Pages
1736–1750.e9
Publication date
30 March 2026
Language
EN